What is the ticker symbol for DiaMedica Therapeutics?

DiaMedica Therapeutics trades under the ticker DMAC on NASDAQ.

What sector does DiaMedica Therapeutics operate in?

DiaMedica Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze DMAC in a portfolio?

PortView shows DMAC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

DiaMedica Therapeutics (DMAC) Stock Analysis

NASDAQHealthcareBiotechnology

$6.60+2.33%

1-year price historyRange $5.30 – $9.39

52-week range$6.60

$5.14$10.42

What DiaMedica Therapeutics does

DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advancing therapeutic solutions for neurological and renal disorders. Its primary drug candidate, DM199, a recombinant human tissue kallikrein-1 protein, is currently undergoing a Phase 2 REDUX trial to assess its efficacy in treating moderate to severe chronic kidney disease linked to Type 1 or Type 2 diabetes. Furthermore, DM199 is being evaluated in Phase 2/3 REMEDY2 trials for acute ischemic stroke patients. In addition to DM199, the company is also developing DM300, which is in its pre-clinical stage for the treatment of various inflammatory conditions. Founded in 2000 and headquartered in Minneapolis, Minnesota, the company was previously known as DiaMedica Inc. before adopting its current name, DiaMedica Therapeutics Inc., in December 2016.

Key metrics

Market cap

$355.63M

P/E (TTM)

-9.30

EPS (TTM)

$-0.71

Beta

0.97

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$6.88

200-day avg

$7.19

52-week high

$10.42

52-week low

$5.14

CEO

Dietrich John Pauls

ETFs linked to DMAC

Broad-market and Healthcare sector ETFs an investor holding DiaMedica Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how DMAC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze DMAC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for DiaMedica Therapeutics?: DiaMedica Therapeutics trades under the ticker DMAC on NASDAQ.
Which exchange is DMAC listed on?: DMAC is listed on NASDAQ.
What sector does DiaMedica Therapeutics operate in?: DiaMedica Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze DMAC in a portfolio?: PortView shows DMAC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.